Eton Pharmaceuticals (ETON) EBT: 2019-2025
Historic EBT for Eton Pharmaceuticals (ETON) over the last 7 years, with Sep 2025 value amounting to -$2.0 million.
- Eton Pharmaceuticals' EBT fell 490.22% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.5 million, marking a year-over-year decrease of 22.18%. This contributed to the annual value of -$3.8 million for FY2024, which is 452.69% down from last year.
- According to the latest figures from Q3 2025, Eton Pharmaceuticals' EBT is -$2.0 million, which was up 22.39% from -$2.5 million recorded in Q2 2025.
- Eton Pharmaceuticals' 5-year EBT high stood at $5.1 million for Q1 2021, and its period low was -$6.1 million during Q3 2021.
- In the last 3 years, Eton Pharmaceuticals' EBT had a median value of -$1.5 million in 2025 and averaged -$951,727.
- As far as peak fluctuations go, Eton Pharmaceuticals' EBT soared by 392.62% in 2023, and later slumped by 490.22% in 2025.
- Quarterly analysis of 5 years shows Eton Pharmaceuticals' EBT stood at $1.0 million in 2021, then dropped by 12.22% to $912,000 in 2022, then plummeted by 320.29% to -$2.0 million in 2023, then surged by 74.56% to -$511,000 in 2024, then slumped by 490.22% to -$2.0 million in 2025.
- Its EBT was -$2.0 million in Q3 2025, compared to -$2.5 million in Q2 2025 and -$1.5 million in Q1 2025.